The INDICAID COVID-19 Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-coV-2 indirect anterior nasal swab specimens from individuals who are suspected of COVID-19. For use by laboratories, pharmacies, urgent care clinics, hospitals, and more, that have a CLIA certified technician to administer and/or supervise the tests.